CIK: 1614936 - Address: C/o Viracta Therapeutics, Inc., 2533 S Coast Hwy 101, Suite 210, Cardiff, CA 92007
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/29/24 19:12
5/25/24
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00099108D
2/27/24 19:56
2/25/24
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00091099D
11/28/23 19:01
11/25/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00091190D
8/29/23 18:49
8/25/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00091281D
5/26/23 19:30
5/25/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00091472D
2/28/23 18:25
2/25/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00091763D
11/29/22 17:21
11/25/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00092054D
8/29/22 21:16
8/25/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00092545D
3/1/22 21:11
2/25/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00095027D
11/29/21 19:51
11/25/21
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPomerantz RogerCADM.d00.00018New18D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact